 |
 |

Cisplatin Potentiation of RadiotherapyLong-term Follow-up
Bruce Leipzig, MD;
Stephen J. Wetmore, MD;
Roberto Putzeys, MD;
James Y. Suen, MD;
Nancy L. Snyderman, MD
Arch Otolaryngol. 1985;111(2):114-118.
Abstract
Thirty-three patients with inoperable squamous cell carcinoma of the head and neck were treated with cisplatin, 15 mg/sq m, administered synchronously with high-dose radiation therapy. Twenty-nine patients (88%) responded to the regimen; of these, 20 had complete regression of all disease. Eight of the 20 had a relapse in less than one year of their treatment. Among those patients who did not have a relapse, the follow-up period was short. It is concluded that a clinical regression response is more likely with this treatment regimen than with radiation therapy alone, and that that response may be a better palliation. Further study of this combination of treatment modalities is warranted.
(Arch Otolaryngol 1985;111:114-118)
Author Affiliations
From the Department of Otolaryngology and Maxillofacial Surgery (Drs Leipzig, Wetmore, Suen, and Snyderman), and the Department of Radiology (Dr Putzeys), Division of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock.
Footnotes
Accepted for publication Oct 5, 1984.
Read before the International Conference on Head and Neck Cancer, Baltimore, July 23, 1984.
Reprint requests to Division of Head and Neck Oncology, Department of Otolaryngology, University of Arkansas for Medical Sciences, Slot 538, 4301 W Markham, Little Rock, AR 72205 (Dr Leipzig).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Preoperative Chemotherapy-Sensitized Radiation Therapy for Cervical Metastases in Head and Neck Cancer
Puc et al.
Arch Otolaryngol Head Neck Surg 2000;126:337-342.
ABSTRACT
| FULL TEXT
Carboplatin-Radiation Interaction in Squamous Cell Carcinoma Cell Lines
Pekkola-Heino et al.
Arch Otolaryngol Head Neck Surg 1992;118:1312-1315.
ABSTRACT
Cisplatin Sensitization to Radiotherapy in Stage IV Squamous Cell Carcinoma of the Head and Neck: A Follow-up Report
Snyderman et al.
Arch Otolaryngol Head Neck Surg 1986;112:1147-1150.
ABSTRACT
|